← REGULATORY CHANGES
FEDERAL REGISTER · NOTICEMarch 18, 2024NOTICE — NO LEGAL EFFECT
Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
What this record is not
Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.
STATUSNOTICE — NO LEGAL EFFECT
EFFECTIVE—
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGDrug
Document type
Notice
Agency
Health and Human Services Department
Published
March 18, 2024
Document number
C1-2024-05178
Docket
FDA-2013-D-0077
The Federal Register publishes no abstract for this document. Read it at the source below.
READ THE FULL DOCUMENT
The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.
View on federalregister.gov →That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.
Create a free account